- AdventHealth

These two preachers’ kids care deeply about staying true to their missions. In episode 2 of the Inspiring Wholeness podcast, AdventHealth Florida CEO Randy Haffner and CrossMarc Services President John Crossman tackle how to avoid “mission drift.”
Haffner asks, “How do you continue to advance yourself and innovate, but at the same time stay connected to those core values?” Listen now to hear more and be sure to subscribe wherever you get your podcasts.
Recent News

AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...

AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism and co-authored by Dr. Corbin introduces a metagenomics-powered approach to...

Mayor Demings, AdventHealth on bridging health care gaps
Discover what’s being accomplished in Central Florida to bridge the health gap with Orange County Mayor Jerry Demings and AdventHealth’s Dr. Alric Simmonds.

Transforming lives of stroke survivors: AdventHealth, Orlando Neurosurgery first in nation to perform 50 Vivistim implant cases
Breakthrough device offers new hope for stroke survivors struggling with rehabilitation following ischemic stroke

AdventHealth Inflammatory Bowel Disease Clinic Adds Intestinal Ultrasound to Help Evaluate and Guide Treatment
Jennifer Seminerio, MD, recently became one of the first in Florida to use intestinal ultrasound (IUS) to help assess and manage treatment of patients with inflammatory bowel disease (IBD). A non...

AdventHealth Daytona Beach Surgeon First in Florida to Perform Robotic-assisted Convergent Hybrid Ablation Procedure
The Convergent Hybrid Ablation procedure has been gaining acceptance as an effective treatment option for long-standing persistent atrial fibrillation (AFib) since the CONVERGE trial data published in...